SentiAR Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $8.5M

  • Investors
  • 18

SentiAR General Information

Description

Developer of a 3D augmented reality holographic platform designed to create a real-time 3D holographic interface for surgical applications. The company's platform features real-time holographic visualization of the patient's actual anatomy using real-time data from catheters and 3D electroanatomic mapping systems, thereby enabling clinicians, radiologists, neurologists, and anesthetists to treat and analyze cardiac ablation therapy to treat arrhythmia patients.

Contact Information

Website
www.sentiar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 212 North Kingshighway Boulevard
  • Box Number 28, Suite 115
  • Saint Louis, MO 63108
  • United States
+1 (612)
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Augmented Reality, SaaS, HealthTech
Corporate Office
  • 212 North Kingshighway Boulevard
  • Box Number 28, Suite 115
  • Saint Louis, MO 63108
  • United States
+1 (612)

SentiAR Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SentiAR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 11-Apr-2023 $8.5M Completed Generating Revenue
8. Early Stage VC (Series A) 01-Dec-2021 Completed Generating Revenue
7. Early Stage VC (Series A) 01-Jan-2021 Completed Generating Revenue
6. Seed Round 16-Apr-2018 Completed Generating Revenue
5. Early Stage VC (Series A) 22-Feb-2018 Cancelled Product In Beta Test
4. Grant 01-Jan-2018 Completed Product In Beta Test
3. Grant 03-Nov-2017 Completed Product In Beta Test
2. Seed Round 31-Aug-2017 $1.1M $1.1M Completed Product In Beta Test
1. University Spin-Out 01-Jan-2017 Completed Startup
To view SentiAR’s complete valuation and funding history, request access »

SentiAR Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-3
Series A-2
Series A-1 157,042 $0.000010 $1.91 $1.91 1x $1.91 1.61%
Series A 2,120,261 $0.000010 $2.39 $2.39 1x $2.39 21.73%
To view SentiAR’s complete cap table history, request access »

SentiAR Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a 3D augmented reality holographic platform designed to create a real-time 3D holographic interface for sur
Surgical Devices
Saint Louis, MO
27 As of 2024

Cambridge, MA
 

Arlington Heights, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SentiAR Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Empatica Venture Capital-Backed Cambridge, MA
Augmedics Venture Capital-Backed Arlington Heights, IL
RealView Venture Capital-Backed Yokneam Illit, Israel
Osso VR Venture Capital-Backed San Francisco, CA
Medivis Venture Capital-Backed New York, NY
You’re viewing 5 of 8 competitors. Get the full list »

SentiAR Patents

SentiAR Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230341932-A1 Two-way communication between head-mounted display and electroanatomic system Pending 22-Apr-2022
US-11452477-B2 Electrogram annotation system Active 25-Oct-2019
US-20210121089-A1 Electrogram annotation system Active 25-Oct-2019
CA-3158776-A1 Electrogram annotation system Pending 25-Oct-2019
EP-4049126-A1 Electrogram annotation system Pending 25-Oct-2019 G16H40/63
To view SentiAR’s complete patent history, request access »

SentiAR Executive Team (5)

Name Title Board Seat
Berk Tas Chief Executive Officer, President & Board Member
Jonathan Silva Co-Founder, Chief Technology Officer & Board Member
Michael Southworth Co-Founder, Lead Developer & Vice President of Technology
Jennifer Silva MD Co-Founder, Chief Medical Officer & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

SentiAR Board Members (8)

Name Representing Role Since
Jennifer Silva MD SentiAR Co-Founder, Chief Medical Officer & Board Member
Jonathan Silva SentiAR Co-Founder, Chief Technology Officer & Board Member
Sean Churchill Self Board Member
Shlomo Shpun Techwald Holding Board Member
Warren Watson Self Board Member
You’re viewing 5 of 8 board members. Get the full list »

SentiAR Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SentiAR Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cultivate(MD) Venture Capital Minority
MedVenture Partners (Japan) Venture Capital Minority
QRM Capital Venture Capital Minority
Harmonix Fund Venture Capital Minority
Keiretsu Forum Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

SentiAR FAQs

  • When was SentiAR founded?

    SentiAR was founded in 2017.

  • Who is the founder of SentiAR?

    Jonathan Silva, Michael Southworth, Jennifer Silva MD, and James Howard are the founders of SentiAR.

  • Who is the CEO of SentiAR?

    Berk Tas is the CEO of SentiAR.

  • Where is SentiAR headquartered?

    SentiAR is headquartered in Saint Louis, MO.

  • What is the size of SentiAR?

    SentiAR has 27 total employees.

  • What industry is SentiAR in?

    SentiAR’s primary industry is Surgical Devices.

  • Is SentiAR a private or public company?

    SentiAR is a Private company.

  • What is the current valuation of SentiAR?

    The current valuation of SentiAR is .

  • What is SentiAR’s current revenue?

    The current revenue for SentiAR is .

  • How much funding has SentiAR raised over time?

    SentiAR has raised $17.2M.

  • Who are SentiAR’s investors?

    Cultivate(MD), MedVenture Partners (Japan), QRM Capital, Harmonix Fund, and Keiretsu Forum are 5 of 18 investors who have invested in SentiAR.

  • Who are SentiAR’s competitors?

    Empatica, Augmedics, RealView, Osso VR, and Medivis are some of the 8 competitors of SentiAR.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »